logoTry Persana

Sequence Bio - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Sequence Bio including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Sequence Bio company logo

Sequence Bio is a biotechnology company focused on genomic research and drug discovery for the Newfoundland and Labrador population.

HeadquartersNA
Team size11-50
FoundedNA

What is Sequence Bio? - Company Overview & Details

Sequence Bio is Sequence Bio is a biotechnology company focused on genomic research and drug discovery for the Newfoundland and Labrador population..

Who Founded Sequence Bio?

Sequence Bio is led by CEO Chris Gardner.

Who are the Key Executives at Sequence Bio? - Leadership Team

Sequence Bio is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Sequence Bio

Chris GardnerCEO

Chief Technology Officer (CTO) of Sequence Bio

Michael S. PhillipsCTO

About Chris Gardner - CEO of Sequence Bio

Chris Gardner serves as the Chief Executive Officer of Sequence Bio, leading the company's strategic vision and operations.

Sequence Bio Company Details & Key Information

How many employees does Sequence Bio have?

Sequence Bio has 11-50 employees.

Sequence Bio Official Website

How much funding has Sequence Bio raised?

Sequence Bio has raised undisclosed amount.

N/A
Total Funding Raised
0
Funding Rounds
N/A
Latest Round

Who are the key investors in Sequence Bio?

Investor Information Not Available

Detailed information about Sequence Bio investors is not currently available in our database.

What are Sequence Bio's future plans?

Future Plans Information Not Available

Detailed information about Sequence Bio's future plans and strategic initiatives is not currently available in our database.

What are the latest news about Sequence Bio?

Sequence Bio has 2 recent news updates covering key business developments and market activities.

Sequence Bio News Overview

2
Recent Articles
Active
Media Coverage
2023-05-31
Latest Update

What is Sequence Bio in the news for?

Sequence Bio is currently featured in news for Rcseng partners with Sequence Bio, Inc. and other significant business developments.

Recent News Articles About Sequence Bio

Article 1
2023-05-31

Rcseng partners with Sequence Bio, Inc.

Royal College of Surgeons in Ireland partnered with Sequence Bio, revealing Newfoundland and Labrador's genetic 'founder effects'.

saltwire.com
Read News
Article 2
2018-01-16

Sequence Bio, Inc. hired Michael S. Phillips as chief scientific officer on Jan 16th '18.

Sequence Bio appointed Dr. Michael S. Phillips as Chief Scientific Officer to lead genomic research and drug discovery.

prnewswire.com
Read News

Sequence Bio FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Sequence Bio including information about founders, CEO, funding history, investors, headquarters location, and company details. 9 frequently asked questions covering key information about the company.

Sequence Bio Questions & Answers - Company Information

Q1

What is Sequence Bio?

Sequence Bio is a biotechnology company focused on genomic research and drug discovery for the Newfoundland and Labrador population.

Q2

Who founded Sequence Bio?

Sequence Bio is led by CEO Chris Gardner.

Q3

Who is the CEO of Sequence Bio?

The CEO of Sequence Bio is Chris Gardner.

Q4

How many employees does Sequence Bio have?

Sequence Bio has 11-50 employees.

Q5

What is Sequence Bio's official website?

You can visit Sequence Bio's official website at http://www.sequencebio.com.

Q6

Who is founder?

Chris Gardner

Q7

Who is cto?

Michael S. Phillips

Q8

What does the company do?

Sequence Bio is a biotechnology company focused on genomic research and drug discovery for the Newfoundland and Labrador population.

Q9

Latest news?

Royal College of Surgeons in Ireland partnered with Sequence Bio, revealing Newfoundland and Labrador's genetic 'founder effects'. Sequence Bio appointed Dr. Michael S. Phillips as Chief Scientific Officer to lead genomic research and drug discovery.

More Information About Sequence Bio

For additional details about Sequence Bio, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.